Neuroprotective effects of fecal microbiota transplantation on MPTP-induced Parkinson's disease mice: Gut microbiota, glial reaction and TLR4/TNF-α signaling pathway

Brain, Behavior, and Immunity

Volumn 70, Issue , 2018, Pages 48-60

  Sun, Meng Fei ^a   Zhu, Ying Li ^a   Zhou, Zhi Lan ^a   Jia, Xue Bing ^a   Xu, Yi Da ^a   Yang, Qin ^a   Cui, Chun ^a   Shen, Yan Qin ^a  

^a JIANGNAN UNIVERSITY   (China)

Author keywords

Glia; Gut brain axis; Microbial dysbiosis; Neuroinflammation; Neurotransmitter; Parkinson's disease; Short chain fatty acids; TLR4 TNF signaling

Indexed keywords

DOPAMINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; NEUROTRANSMITTER; RNA 16S; SEROTONIN; SHORT CHAIN FATTY ACID; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR; NEUROPROTECTIVE AGENT; TLR4 PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; BACTERIUM; C57BL 6 MOUSE; CELL ACTIVATION; CELL FUNCTION; CLOSTRIDIALES; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; DOWN REGULATION; DYSBIOSIS; ENTEROBACTERIALES; FECAL MICROBIOTA TRANSPLANTATION; FECES; FIRMICUTES; GLIA CELL; INTESTINE FLORA; MALE; MICROGLIA; MOTOR DYSFUNCTION; MOTOR PERFORMANCE; MOUSE; NERVOUS SYSTEM INFLAMMATION; NEUROPROTECTION; NONHUMAN; PARKINSON DISEASE; PHYLUM; PHYSICAL DISEASE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY RNA SEQUENCE; SIGNAL TRANSDUCTION; SUBSTANTIA NIGRA; TURICIBACTERALES; UPREGULATION; ANIMAL; BRAIN; C57BL MOUSE; DISEASE MODEL; DRUG EFFECT; GENETICS; GLIA; METABOLISM; MICROBIOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; PROCEDURES;

ANIMALS; BRAIN; DISEASE MODELS, ANIMAL; DYSBIOSIS; FECAL MICROBIOTA TRANSPLANTATION; FECES; GASTROINTESTINAL MICROBIOME; MALE; MICE; MICE, INBRED C57BL; MICROGLIA; NEUROGLIA; NEUROPROTECTIVE AGENTS; PARKINSON DISEASE; RNA, RIBOSOMAL, 16S; TOLL-LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR-ALPHA;

EID: 85042363965     PISSN: 08891591     EISSN: 10902139     Source Type: Journal    
DOI: 10.1016/j.bbi.2018.02.005     Document Type: Article

References (59)

1. Abreu, M.T., Vora, P., Faure, E., Thomas, L.S., Arnold, E.T., Arditi, M., Decreased expression of Toll-like receptor-4 and MD-2 correlates with intestinal epithelial cell protection against dysregulated proinflammatory gene expression in response to bacterial lipopolysaccharide. J. Immunol. 167 (2001), 1609–1616.
2. Ahmed, M., Gwairgi, M., Ghanem, A., Conventional Chiralpak ID vs. Capillary Chiralpak ID-3 Amylose Tris-(3-Chlorophenylcarbamate)-Based Chiral Stationary Phase Columns for the Enantioselective HPLC Separation of Pharmaceutical Racemates. Chirality 26 (2014), 677–682.
3. Alhasson, F., Das, S., Seth, R., Dattaroy, D., Chandrashekaran, V., Ryan, C.N., Chan, L.S., Testerman, T., Burch, J., Hofseth, L.J., Horner, R., Nagarkatti, M., Nagarkatti, P., Lasley, S.M., Chatterjee, S., Altered gut microbiome in a mouse model of Gulf War Illness causes neuroinflammation and intestinal injury via leaky gut and TLR4 activation. PLoS One, 12, 2017.
4. Bedarf, J.R., Hildebrand, F., Coelho, L.P., Sunagawa, S., Bahram, M., Goeser, F., Bork, P., Wullner, U., Functional implications of microbial and viral gut metagenome changes in early stage L-DOPA-naive Parkinson's disease patients. Genome Med., 9, 2017.
5. Booth, H.D.E., Hirst, W.D., Wade-Martins, R., The role of astrocyte dysfunction in parkinson's disease pathogenesis. Trends Neurosci. 40 (2017), 358–370.
6. Braniste, V., Al-Asmakh, M., Kowal, C., Anuar, F., Abbaspour, A., Toth, M., Korecka, A., Bakocevic, N., Guan, N.L., Kundu, P., Gulyas, B., Halldin, C., Hultenby, K., Nilsson, H., Hebert, H., Volpe, B.T., Diamond, B., Pettersson, S., The gut microbiota influences blood-brain barrier permeability in mice. Sci Transl Med., 6, 2014.
7. Cammarota, G., Pecere, S., Laniro, G., Masucci, L., Curro, D., Principles of DNA-Based gut microbiota assessment and therapeutic efficacy of fecal microbiota transplantation in gastrointestinal diseases. Dig Dis. 34 (2016), 279–285.
8. Cani, P.D., Bibiloni, R., Knauf, C., Neyrinck, A.M., Neyrinck, A.M., Delzenne, N.M., Burcelin, R., Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice. Diabetes 57 (2008), 1470–1481.
9. Cao, Q., Qin, L.Y., Huang, F., Wang, X.S., Yang, L., Shi, H.L., Wu, H., Zhang, B.B., Chen, Z.Y., Wu, X.J., Amentoflavone protects dopaminergic neurons in MPTP-induced Parkinson's disease model mice through PI3K/Akt and ERK signaling pathways. Toxicol Appl. Pharmacol. 319 (2017), 80–90.
10. Caporaso, J.G., Kuczynski, J., Stombaugh, J., Bittinger, K., Bushman, F.D., Costello, E.K., Fierer, N., Pena, A.G., Goodrich, J.K., Gordon, J.I., Huttley, G.A., Kelley, S.T., Knights, D., Koenig, J.E., Ley, R.E., Lozupone, C.A., McDonald, D., Muegge, B.D., Pirrung, M., Reeder, J., Sevinsky, J.R., Turnbaugh, P.J., Walters, W.A., Widmann, J., Yatsunenko, T., Zaneveld, J., Knight, R., QIIME allows analysis of high-throughput community sequencing data. Nat. Methods 7 (2010), 335–336.
11. Cheng, J., Palva, A.M., de Vos, W.M., Satokari, R., Contribution of the intestinal microbiota to human health: from birth to 100 years of age. Curr. Top. Microbiol. Immunol. 358 (2013), 323–346.
12. Claesson, M.J., O'Sullivan, O., Wang, Q., Nikkila, J., Marchesi, J.R., Smidt, H., de Vos, W.M., Ross, R.P., O'Toole, P.W., Comparative analysis of pyrosequencing and a phylogenetic microarray for exploring microbial community structures in the human distal intestine. PLoS One, 4, 2009, e6669.
13. Dauer, W., Przedborski, S., Parkinson's disease: mechanisms and models. Neuron 39 (2003), 889–909.
14. De Smedt, T., Pajak, B., Muraille, E., Lespagnard, L., Heinen, E., De Baetselier, P., Urbain, J., Leo, O., Moser, M., Regulation of dendritic cell numbers and maturation by lipopolysaccharide in vivo. J. Exp. Med. 184 (1996), 1413–1424.
15. Depboylu, C., Stricker, S., Ghobril, J.P., Oertel, W.H., Priller, J., Hoglinger, G.U., Brain-resident microglia predominate over infiltrating myeloid cells in activation, phagocytosis and interaction with T-lymphocytes in the MPTP mouse model of Parkinson disease. Exp. Neurol. 238 (2012), 183–191.
16. Dutta, G., Barber, D.S., Zhang, P., Doperalski, N.J., Liu, B., Involvement of dopaminergic neuronal cystatin C in neuronal injury-induced microglial activation and neurotoxicity. J. Neurochem. 122 (2012), 752–763.
17. Edgar, R.C., Search and clustering orders of magnitude faster than BLAST. Bioinformatics 26 (2010), 2460–2461.
18. Elinav, E., Strowig, T., Kau, A.L., Henao-Mejia, J., Thaiss, C.A., Booth, C.J., Peaper, D.R., Bertin, J., Eisenbarth, S.C., Gordon, J.I., Flavell, R.A., NLRP6 inflammasome regulates colonic microbial ecology and risk for colitis. Cell 145 (2011), 745–757.
19. Evrensel, A., Ceylan, M.E., Fecal microbiota transplantation and its usage in neuropsychiatric disorders. Clin. Psychopharmacol. Neurosci. 14 (2016), 231–237.
20. Goldstein, D.S., Sewell, L., Sharabi, Y., Autonomic dysfunction in PD: a window to early detection?. J. Neurol. Sci. 310 (2011), 118–122.
21. Grenham, S., Clarke, G., Cryan, J.F., Dinan, T.G., Brain-gut-microbe communication in health and disease. Front. Physiol., 2, 2011, 94.
22. Guo, H., Shi, F., Li, M.J., Liu, Q.Q., Yu, B., Hu, L.M., Neuroprotective effects of Eucommia ulmoides Oliv. and its bioactive constituent work via ameliorating the ubiquitin-proteasome system. BMC Complement Altern. Med., 15, 2015.
23. Hamilton, M.J., Weingarden, A.R., Sadowsky, M.J., Khoruts, A., Standardized frozen preparation for transplantation of fecal microbiota for recurrent Clostridium difficile infection. Am. J. Gastroenterol. 107 (2012), 761–767.
24. Hefazi, M., Patnaik, M.M., Hogan, W.J., Litzow, M.R., Pardi, D.S., Khanna, S., Safety and efficacy of fecal microbiota transplant for recurrent clostridium difficile infection in patients with cancer treated with cytotoxic chemotherapy: a single-institution retrospective case series. Mayo Clin. Proc. 92 (2017), 1617–1624.
25. Heijtza, R.D., Wang, S.G., Anuar, F., Qian, Y., Bjorkholm, B., Samuelsson, A., Hibberd, M.L., Forssberg, H., Pettersson, S., Normal gut microbiota modulates brain development and behavior. Proc. Natl. Acad. Sci. U.S.A. 108 (2011), 3047–3052.
26. Hill-Burns, E.M., Debelius, J.W., Morton, J.T., Wissemann, W.T., Lewis, M.R., Wallen, Z.D., Peddada, S.D., Factor, S.A., Molho, E., Zabetian, C.P., Knight, R., Payami, H., Parkinson's disease and parkinson's disease medications have distinct signatures of the gut microbiome. Mov. Disord. 32 (2017), 739–749.
27. Houser, M.C., Tansey, M.G., The gut-brain axis: is intestinal inflammation a silent driver of Parkinson's disease pathogenesis?. NPJ. Parkinsons. Dis., 3, 2017, 3.
28. Jankovic, J., Parkinson's disease: clinical features and diagnosis. J. Neurol. Neurosurg. Psychiatry 79 (2008), 368–376.
29. Kang, D.W., Adams, J.B., Gregory, A.C., Borody, T., Chittick, L., Fasano, A., Khoruts, A., Geis, E., Maldonado, J., McDonough-Means, S., Pollard, E.L., Roux, S., Sadowsky, M.J., Lipson, K.S., Sullivan, M.B., Caporaso, J.G., Krajmalnik-Brown, R., Microbiota Transfer Therapy alters gut ecosystem and improves gastrointestinal and autism symptoms: an open-label study. Microbiome, 5, 2017, 10.
30. Keshavarzian, A., Green, S.J., Engen, P.A., Voigt, R.M., Naqib, A., Forsyth, C.B., Mutlu, E., Shannon, K.M., Colonic bacterial composition in Parkinson's disease. Mov. Disord. 30 (2015), 1351–1360.
31. Khoruts, A., Weingarden, A.R., Emergence of fecal microbiota transplantation as an approach to repair disrupted microbial gut ecology. Immunol. Lett. 162 (2014), 77–81.
32. Kim, J.S., Sung, H.Y., Gastrointestinal autonomic dysfunction in patients with parkinson's disease. J. Mov. Disord. 8 (2015), 76–82.
33. Klindworth, A., Pruesse, E., Schweer, T., Peplies, J., Quast, C., Horn, M., Glockner, F.O., Evaluation of general 16S ribosomal RNA gene PCR primers for classical and next-generation sequencing-based diversity studies. Nucl. Acids Res., 41, 2013, e1.
34. Konturek, P.C., Koziel, J., Dieterich, W., Haziri, D., Wirtz, S., Glowczyk, I., Konturek, K., Neurath, M.F., Zopf, Y., Successful therapy of clostridium difficile infection with fecal microbiota transplantation. J. Physiol. Pharmacol. 67 (2016), 859–866.
35. Kumar, R., Yi, N.J., Zhi, D.G., Eipers, P., Goldsmith, K.T., Dixon, P., Crossman, D.K., Crowley, M.R., Lefkowitz, E.J., Rodriguez, J.M., Morrow, C.D., Identification of donor microbe species that colonize and persist long term in the recipient after fecal transplant for recurrent Clostridium difficile. NPJ Biofilms Microbi., 3(12), 2017, 3.
36. Kuribara, H., Higuchi, Y., Tadokoro, S., Effects of central depressants on rota-rod and traction performances in mice. Jpn. J. Pharmacol. 27 (1977), 117–126.
37. Li, W., Wu, X., Hu, X., Wang, T., Liang, S., Duan, Y., Jin, F., Qin, B., Structural changes of gut microbiota in Parkinson's disease and its correlation with clinical features. Sci. China Life Sci., 2017.
38. Lozupone, C., Knight, R., UniFrac: a new phylogenetic method for comparing microbial communities. Appl. Environ. Microbiol. 71 (2005), 8228–8235.
39. Magoc, T., Salzberg, S.L., FLASH: fast length adjustment of short reads to improve genome assemblies. Bioinformatics 27 (2011), 2957–2963.
40. Mayer, E.A., Gut feelings: the emerging biology of gut-brain communication. Nat. Rev. Neurosci. 12 (2011), 453–466.
41. Mitchell, R.W., On, N.H., Del Bigio, M.R., Miller, D.W., Hatch, G.M., Fatty acid transport protein expression in human brain and potential role in fatty acid transport across human brain microvessel endothelial cells. J. Neurochem. 117 (2011), 735–746.
42. Nagalingam, N.A., Kao, J.Y., Young, V.B., Microbial ecology of the murine gut associated with the development of dextran sodium sulfate-induced colitis. Inflamm. Bowel Dis. 17 (2011), 917–926.
43. O'Mahony, S.M., Clarke, G., Borre, Y.E., Dinan, T.G., Cryan, J.F., Serotonin, tryptophan metabolism and the brain-gut-microbiome axis. Behav. Brain Res. 277 (2015), 32–48.
44. Petrov, V.A., Saltykova, I.V., Zhukova, I.A., Alifirova, V.M., Zhukova, N.G., Dorofeeva, Y.B., Tyakht, A.V., Kovarsky, B.A., Alekseev, D.G., Kostryukova, E.S., Mironova, Y.S., Izhboldina, O.P., Nikitina, M.A., Perevozchikova, T.V., Fait, E.A., Babenko, V.V., Vakhitova, M.T., Govorun, V.M., Sazonov, A.E., Analysis of gut microbiota in patients with Parkinson's disease. Bull Exp. Biol. Med. 162 (2017), 734–737.
45. Qin, L.Y., Wu, X.F., Block, M.L., Liu, Y.X., Breese, G.R., Hong, J.S., Knapp, D.J., Crews, F.T., Systemic LPS causes chronic neuroinflammation and progressive neurodegeneration. Glia 55 (2007), 453–462.
46. Rakoff-Nahoum, S., Paglino, J., Eslami-Varzaneh, F., Edberg, S., Medzhitov, R., Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis. Cell 118 (2004), 229–241.
47. Ransohoff, R.M., How neuroinflammation contributes to neurodegeneration. Science 353 (2016), 777–783.
48. Sampson, T.R., Debelius, J.W., Thron, T., Janssen, S., Shastri, G.G., Ilhan, Z.E., Challis, C., Schretter, C.E., Rocha, S., Gradinaru, V., Chesselet, M.F., Keshavarzian, A., Shannon, K.M., Krajmalnik-Brown, R., Wittung-Stafshede, P., Knight, R., Mazmanian, S.K., Gut Microbiota regulate motor deficits and neuroinflammation in a model of Parkinson's disease. Cell, 167(1469–1480), 2016, e1412.
49. Scheperjans, F., Aho, V., Pereira, P.A., Koskinen, K., Paulin, L., Pekkonen, E., Haapaniemi, E., Kaakkola, S., Eerola-Rautio, J., Pohja, M., Kinnunen, E., Murros, K., Auvinen, P., Gut microbiota are related to Parkinson's disease and clinical phenotype. Mov. Disord. 30 (2015), 350–358.
50. Schuijt, T.J., Lankelma, J.M., Scicluna, B.P., e Melo, F.D., Roelofs, J.J.T.H., de Boer, J.D., Hoogendijk, A.J., de Beer, R., de Vos, A., Belzer, C., de Vos, W.M., van der Poll, T., Wiersinga, W.J., The gut microbiota plays a protective role in the host defence against pneumococcal pneumonia. Gut 65 (2016), 575–583.
51. Tritsch, N.X., Sabatini, B.L., Dopaminergic modulation of synaptic transmission in cortex and striatum. Neuron 76 (2012), 33–50.
52. Ubeda, C., Bucci, V., Caballero, S., Djukovic, A., Toussaint, N.C., Equinda, M., Lipuma, L., Ling, L.L., Gobourne, A., No, D., Taur, Y., Jenq, R.R., van den Brink, M.R.M., Xavier, J.B., Pamer, E.G., 2013.
53. Unger, M.M., Spiegel, J., Dillmann, K.U., Grundmann, D., Philippeit, H., Burmann, J., Fassbender, K., Schwiertz, A., Schafer, K.H., Short chain fatty acids and gut microbiota differ between patients with Parkinson's disease and age-matched controls. Parkinsonism Relat. Disord. 32 (2016), 66–72.
54. Vijay, N., Morris, M.E., Role of monocarboxylate transporters in drug delivery to the brain. Curr. Pharm. Des. 20 (2014), 1487–1498.
55. Vinolo, M.A.R., Rodrigues, H.G., Nachbar, R.T., Curi, R., Regulation of inflammation by short chain fatty acids. Nutrients 3 (2011), 858–876.
56. Wang, Y., Kasper, L.H., The role of microbiome in central nervous system disorders. Brain Behav. Immun. 38 (2014), 1–12.
57. Zhang, J., Zhu, C., Guan, R., Xiong, Z., Zhang, W., Shi, J., Sheng, Y., Zhu, B., Tu, J., Ge, Q., Chen, T., Lu, Z., Microbial profiles of a drinking water resource based on different 16S rRNA V regions during a heavy cyanobacterial bloom in Lake Taihu, China. Environ. Sci. Pollut. Res. Int. 24 (2017), 12796–12808.
58. Zhao, L., Wang, G., Siegel, P., He, C., Wang, H., Zhao, W., Zhai, Z., Tian, F., Zhao, J., Zhang, H., Sun, Z., Chen, W., Zhang, Y., Meng, H., Quantitative genetic background of the host influences gut microbiomes in chickens. Sci. Rep., 3, 2013, 1163.
59. Zhao, X.D., Wang, F.X., Cao, W.F., Zhang, Y.H., Li, Y., TLR4 signaling mediates AP-1 activation in an MPTP-induced mouse model of Parkinson's disease. Int. Immunopharmacol. 32 (2016), 96–102.